Toxoplasma gondii, IgM-13515

Test info

  
Toxoplasma gondii, IgM
  
13515
  
LAB13515
  
TOXOIGM
  
Toxoplasmosis acute antibodies
  

Qualitative determination of IgM antibodies to Toxoplasma gondii (T. gondii) to aid in the presumptive diagnosis of acute or recent T. gondii infection, including in pregnant women. It is recommended that IgM testing be performed in conjunction with IgG testing. A positive IgM but negative IgG result should be viewed with suspicion; the patient should be retested two weeks after the first test. If the patient is pregnant and IgG/IgM positive, an IgG avidity test should be performed.

  
  • Low levels of Toxoplasma IgM may persist for months to years after an initial infection.
  • This test has not been cleared/approved by the FDA for blood/plasma donor screening.

Specimen

  
Serum
  
  
0.5 mL
  
0.2 mL
  

Immediatley following collection, mix sample by gently inverting 5 times

  
  1. Allow sample to clot for a minimum of 30 minutes
  2. Spin within two (2) hours of sample collection
  

Gold serum separator (SST) tube

  
  
  1. Allow sample to clot
  2. Spin
  3. Transfer serum to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as serum, within two (2) hours of sample collection
  
  

Refrigerated (preferred) - 14 days

Ambient - 14 days

Frozen - 14 days

Freeze/thaw cycles: stable x4

  
  • Hemolysis
  • Lipemia
  • Gross bacterial contamination

Performance

  
LabCorp Burlington (096651): R-LC
  
Daily
  
1 - 2 days
  

Chemiluminescent immunoassay (CLIA)

Clinical and Interpretive info

  

Negative: <8.0 AU/mL

Equivocal: 8.0 - 9.9 AU/mL

Positive:  >9.9 AU/mL

Billing

  
86778
  
Result 5390-0

Tracking

  
04/11/2019
  
06/13/2023
  
05/30/2023